2026 Annual Conference - Bios

Ashwin works extensively with Forian’s robust RWD, including both internal partners and external clients, towards the end delivery of analytic solutions to our clients. Ashwin has worked in the RWD space for multiple years, having roles in Sales Enablement and Integrated Solutions Design. Combined with his experience as an Epidemiologist, Ashwin uses both clinical and commercial experience to support Forian’s client types across the Life Science and Healthcare landscape. Prior to joining Forian, Ashwin spent 3+ years at Decision Resources Group and worked at a Center for Medicare and Medicaid Services (CMS) federal contractor. He holds an MPH in Epidemiology from Boston University.

Simran is a healthcare analytics professional with 6 years of experience across healthcare consulting and commercial analytics. Her earlier experience includes delivering advanced analytics solutions in physician targeting, patient analytics, and market mix modeling. At Bristol Myers Squibb, she supports commercial analytics initiatives in AI/ML driven forecasting and contributes to global stakeholder management solutions through ETL engineering, workflow automation, and product performance analytics, helping enable data-driven decision making. She holds a Bachelor’s degree in Economics (Hons.) from Shri Ram College of Commerce and a Master of Science in Economics.

Vipin Banchariya is an Associate Principal with ZS, based in the New York office. He is a leader in the Patient Strategy and Services space, focused on developing data-, analytics-, and AI-driven solutions to enhance patient experience and outcomes.

Vipin brings over 15 years of experience partnering with large and emerging life sciences organizations to deliver impactful commercial and patient experience programs. He specializes in leading digital transformations, with a strong emphasis on embedding analytics and AI into operations to drive informed decision-making and measurable business impact.

Bharath Bommakanti is a Senior Manager of Data Science at McKesson Compile, where he leads Data Science initiatives to improve the healthcare outcomes for U.S. patient populations through deployment of Generative AI applications, data augmentation and standardization solutions. Holding close to 10 years of experience working in U.S. Healthcare data and analytics, he is proficient in ML & DL model development, model deployment, and leveraging Gen AI for healthcare data improvement and applications.

Paul is an experienced commercial strategist with more than two decades of leadership in developing innovative solutions to enhance business performance. He has a proven record of generating insights that inform commercial strategy and drive measurable, execution‑focused results. Paul regularly contributes to industry thought leadership, offering strategic guidance and practical executional frameworks. He has presented at major conferences, including PMSA, and has authored multiple publications.

Bob currently serves as an AI Architect, leading the design and delivery of scalable AI, generative AI, and Agentic AI solutions that translate business needs into measurable enterprise value. He drives the development of secure, compliant, and sustainable architectures across data, analytics, machine learning, cloud platforms, and MLOps/LLMops, enabling organizations to accelerate decision-making and improve operational efficiency. Bob partners closely with business leaders, product teams, engineers, and cross-functional stakeholders to align strategy, technology, and execution, with a strong focus on responsible AI and enterprise transformation in regulated healthcare environments.

Karin Hayes is Senior Vice President of Analytics Products and Services, where she leads the development of innovative media and analytics solutions that optimize omni-channel healthcare marketing and inform smarter commercial decisions. Previously, she led product management at ICON Symphony Health, partnering with leading life sciences organizations to deliver award-winning sales and marketing technologies powered by machine learning and advanced analytics. With over 15 years in the pharmaceutical industry, Karin is driven by a commitment to improving the connection between patients and their healthcare providers to help ensure better care and outcomes.

Eric Chung is Co-Founder and Co-CEO, at Prospection, where he leads the expansion of AI-driven patient analytics into the US market. Originally from Australia, Eric founded Prospection over a decade ago, partnering with government and more than 50 pharmaceutical companies to unlock real-world patient data and generate actionable insights across Australia and Japan. Building on this experience, Prospection has pioneered transformer-based predictive models that anticipate patient progression and enable more precise commercial decision-making. Eric now focuses on bringing forward-looking AI capabilities to US pharma and biotech organizations to improve patient identification and go-to-market effectiveness.

30 years in marketing and market research across multiple industries (CPG, Financial, Pharmaceutical, etc.) and designs (concept testing, advertising, brand equity, etc.)

Chad Dau is AVP of Decision Analytics and Optimization at Eli Lilly and Company, where he leads teams applying advanced analytics, simulation, optimization and AI to decision-making. His current work spans simulation, optimization, behavioral sciences, responsible AI governance, and applications of AI to strategic planning.

Chad has been in the industry over 25 years, serving as Executive Director of Advanced Analytics and Decision Science at Astellas Pharma prior to joining Lilly. Earlier in his career, he held marketing analytic positions at Marketing Analytics Inc, Takeda and NDC Health. He holds a Bachelor from the University of Chicago, an MBA from the Kellogg School of Management at Northwestern University, and an MPH from Michigan State University.

Varsha is a Partner at ProcDNA, and specializes in brand and marketing strategy, omnichannel implementation, and campaign optimizations. She brings over 15 years of experience working across marketing agencies as well as consulting companies, providing data driven insights to marketing and analytics teams across healthcare clients.

Daniel Fracas is a Director of Client Engagement with more than 30 years of experience advising life sciences organizations on turning complex data into measurable business and patient outcomes. He has led large-scale real‑world evidence, analytics, and data platform initiatives, including multi‑year data lake programs for global pharmaceutical companies. Dan specializes in integrating AI-driven insights, care gap signals, and self‑service dashboards into decision workflows across clinical, commercial, and market access teams. His work spans population health analytics, disease epidemiology, and data‑driven go‑to‑market strategy across multiple therapeutic areas.

A frequent speaker on AI adoption and data storytelling, Dan is known for helping organizations move from static reporting to actionable intelligence at scale.

Aparajit is a Principal at Viscadia, where he leads the consulting function and India operations. He brings over 17 years of experience in forecasting, with a strong track record of helping global life sciences companies apply advanced analytics and AI enabled commercial insights to drive business growth.

His leadership spans practice development, client engagement, and the design of innovative, AI driven forecasting and decision support solutions. Aparajit has played a key role in embedding intelligent automation, scalable analytics, and AI approaches into commercial forecasting workflows. He is known for delivering high-impact forecasting and digital transformation strategies that enable clients to make data-driven decisions and optimize commercial performance.

John Grecsek leads the development of forecasting models, tools, training, and enterprise‑wide best practices that support both in‑line and pre‑launch products. With a background in finance, deep analytics expertise, and Agentic AI framework, he focuses on improving forecast accuracy, enhancing risk/opportunity visibility, and driving innovation to advance data‑driven decision‑making.

Pharma analytics consultant with ~6 years of experience partnering with commercial teams to drive data-driven decision-making across specialty brands with specific experience in oncology. Expertise in omnichannel, launch & patient analytics, building scalable, enterprise-grade analytics solutions using claims and real-world data. Proven track record of translating advanced analytics into actionable strategies that inform commercial decision making, optimization, and brand performance. Experienced in leading cross-functional engagements and enabling adoption of analytics across brand, field, and omnichannel teams.

Shekhar Gupta is an AVP, Data Analytics & AI at Indegene with deep expertise in commercial pharmaceutical analytics, insights, and strategy. He brings extensive experience across areas such as sales force effectiveness, forecasting, brand analytics, and new drug launch analytics. With a strong foundation in data strategy and AI/ML, he focuses on integrating data with business context to drive decision-making. He has previously held leadership roles at Novartis and Cognizant, working across analytics transformation and data solutions.

Dr. Huang currently leads the digital health AI/ML product strategy for Alcon’s vision care and surgical businesses. He oversees the delivery of data and analytics capabilities that enhance digital health product development and commercial execution.

Previously, Dr. Huang held senior leadership roles at Pfizer and Regeneron, where he led global teams delivering digital, data, and analytics initiatives across R&D, manufacturing, and supply chain operations. Dr. Huang holds a PhD in Chemometrics from the Norwegian University of Science and Technology and an MBA in Finance and Supply Chain Management from Rutgers University.

Arun has 20+ years of consulting experience in pharma commercial excellence, forecasting, marketing analytics, and performance measurement. He specializes in data, insights, and analytics, with deep expertise in AI, machine learning, and generative AI applications, and driving large-scale analytics transformations.

Archana has 16+ years of experience in the industry and deep expertise in commercial insights, strategy, primary market research, portfolio reporting as well as patient claims and secondary data management. Archana leads Oncology Patient Journey Analytics at Daiichi Sankyo, across multiple indications partnering closely with commercial teams to drive strategic decision-making through insights and analytics.

Jonathan has pioneered embedding AI in operations at healthcare companies. He has shaped and scaled innovative approaches across customer engagement, leveraging RWE, acceleration of clinical trials and (Gen)AI powered intelligence and efficiency.

He has supported clients to define and execute numerous transformation programs resulting in accelerated growth. He has deep experience combining rapid value addressing business priorities with establishing scalable foundations across data, AI, tech, capabilities, processes and culture. He has worked with providers, payers and governments as well as life science companies in the U.S., Europe, Asia and the Middle East on data and AI strategy. He is leading Digital and AI solutions at Trinity.

Esra Karahan is Director of Access Strategy for the Respiratory Franchise at Sanofi, where she leads market access and contracting strategy for Dupixent across multiple indications. With deep expertise in payer engagement, pricing strategy, and value demonstration, Esra drives innovative approaches to securing and maintaining optimal access in an increasingly complex reimbursement landscape. She holds a proven track record in translating clinical value into compelling payer narratives and developing data-driven access solutions that balance patient access with commercial objectives.

Lori leads the Medical & Scientific Affairs Practice at Inizio Ignite, Putnam and plays a key role in advancing AI through her work on Inizio’s GenAI Council and as Chair of Putnam’s AI Executive Committee. She is a recognized thought leader on AI in Medical Affairs, co-authoring the MAPS GenAI white paper and frequently speaking on the topic while partnering with clients to design tailored AI solutions. Lori brings deep experience across consulting, pharma, and academia, including founding Bench Wing and previously serving as President at CDM. She holds an RPh and PharmD, along with a postdoctoral fellowship in critical care and infectious diseases from the University of Minnesota.

Karthikeyan is a data & Analytics professional with ~11 years of experience, leveraging advanced analytics and real-world data (RWD) to drive patient and commercial insights across therapeutic areas. He is experienced in building scalable data platforms, automated analytics workflows, and GenAI-driven solutions to enable faster, data-driven decision-making. Karthikeyan has a proven track record in delivering impactful insights across patient journey and HCP targeting, while leading cross-functional teams and driving strong client engagement.

Ganhui Lan, PhD, is Vice President of Data Science & Machine Learning at Genentech, a member of the Roche group, where he leads the use of data, analytics, and AI to transform patient and customer experiences. His work focuses on modernizing engagement, improving decision-making, and accelerating access to medicines across the biopharma industry.

Ben brings over 25 years of experience in data, AI, and software development across the healthcare and high-tech industries. He has held leadership roles in both startups and Fortune 500 companies, consistently driving business transformation and delivering exceptional results. As VP of Data Product & Management at Genentech, Ben leads the enterprise-wide data strategy, governance, and development of scalable, high-quality data platforms and products. Previously, he served as VP and Global Head of Digital Health Data & Analytics at Alcon, and as Co-founder and Head of Engineering and Data Science at BrightInsight.

Michele Maier is VP of Therapeutic Area Analytics & Insights at Boehringer Ingelheim, with more than 30 years of experience in the pharmaceutical industry. Her career has spanned marketing, market analytics, and strategic insights, with a consistent focus on translating data into commercial and medical impact. Michele's A&I organization serves as a key business partner to Marketing, Medical, and Value & Access from asset development through loss of exclusivity delivering critical insights that optimize strategy and investment decisions across the product lifecycle. Michele works closely with Boehringer’s AI Center of Excellence, focusing on embedding AI into insight generation and integration, and on developing KPI frameworks to measure and scale the value of AI-driven decision-making.

Barun is a Life Sciences strategist and technologist with more than 20 years of experience across R&D and commercial analytics. His work focuses on applying advanced analytics and AI to pharmaceutical and biotech decision-making. Prior to Humigent, he held leadership roles at ZS, Deloitte, PharmaACE, and Boston Scientific. Barun holds more than 70 patents in the Life Sciences field. He earned a BS in Electrical Engineering from IIT Kharagpur, an MS in Biomedical Engineering from Johns Hopkins University, and an MBA from The Wharton School, where he graduated as a Palmer Scholar.

Adell Mendes, Director of Data Strategy, Products & Governance at AstraZeneca, leads data management, governance, and AI-based decision making. She improves data quality, interoperability, and lifecycle processes, collaborating with IT and architecture to enhance platforms and analytics scalability. Adell works across the organization to deliver compliant, value-driven data solutions for business priorities and confident decision-making. With an MBA and MPH, she combines business, data, and population health expertise in analytics transformation.

Ajit leads the Customer Engagement and Digital Transformation team at Johnson and Johnson North America Innovative Medicine, delivering data, AI, content and media strategies that drive business impact and customer experience across all businesses and functions. Ajit is responsible for the strategy and execution of AI strategies starting with commercial, expanding to medical affairs and most recently to patient services. He had led the design, development and deployment of novel generative and agentic AI capabilities which are enabling Go to Market Models.

Ajit joined J&J in 2015 after a decade in consulting and biotech. He is a trained Pharmacist and received a PhD from the University of Georgia.

As Director of Bio-Pharma Medical Evidence at AstraZeneca, he translates evidence into measurable patient impact at scale. With 12+ years in pharma and healthcare, he leads therapeutic area strategy, omnichannel scientific engagement, KOL/HCP mapping, and evidence-to-impact execution. He builds AI-enabled frameworks linking RWE, field medical activity, and scientific engagement to decision-relevant outcomes. He is pursuing a DHSc in Healthcare Leadership focused on Medical Affairs transformation.

Arif Nathoo, MD, is co-founder and CEO at Komodo Health, where he oversees data sciences, engineering, and product development. With over 20 years in healthcare and life sciences, he previously led McKinsey's healthcare and medical affairs practices, helping enterprise clients with strategy, finance, and organization building. He has conducted research in instructional technologies and medical devices, with multiple peer-reviewed publications. Arif holds an AM in molecular and cellular biology from Harvard College, an MD from Harvard Medical School, and an MPA in health policy from the Harvard Kennedy School.

Constantine Papageorgiou is Chief Data Scientist at SENTIER Analytics, where he develops machine learning and agent-based simulation models to evaluate promotional response and support engagement strategy decisions in pharmaceutical commercial analytics. His work focuses on modeling how individual and system-level behaviors evolve in response to promotional activity. He previously served as a Senior Portfolio Manager at Acadian Asset Management, where he developed quantitative investment strategies using advanced modeling and natural language processing. He holds a PhD in Electrical Engineering and Computer Science from MIT, with research in statistical machine learning, computer vision, and pattern recognition.

Ravi is a builder at heart who finds his "zen" at the intersection of deep engineering and product craft. Currently leading high-scale Data Platforms at McKesson, he has spent 15+ years architecting global ecosystems serving 1Bn+ users across e-commerce, fintech, and healthcare spanning both B2C and B2B domains. Ravi specializes in the "un-breakable" stuff - mission-critical migrations, high-performance infrastructure and state of the art user experience. A seasoned speaker, he’s best known for sharing "scars from the trenches" and proving that even the most daunting technical challenges can be reshaped into elegant, scalable user experiences.

Jingjing Qu is a Director of Omni-Channel Strategy & Analytics at Bausch + Lomb, where she leads advanced analytics and AI-driven initiatives to optimize commercial execution across ophthalmic pharmaceuticals. She specializes in translating real-world data into actionable insights that improve targeting, engagement, and prescription growth across eye care professionals. Her work supports key therapeutic areas such as dry eye and glaucoma by enabling more precise, data-driven decision-making in sales and marketing. Jingjing is known for integrating machine learning and omnichannel strategy to drive measurable impact in pharmaceutical commercialization.

Brett Ramos is a commercial strategy and analytics leader with deep expertise in the CNS pharmaceutical landscape, having spent his career at organizations including Acadia Pharmaceuticals, Amgen and ZS. He has led initiatives across Commercial Operations, New Business Development, and Advanced Analytics, leveraging AI and ML to support drug portfolio launches and refine go-to-market strategies. Brett is passionate about translating data-driven insights into solutions that advance patient care and meet the evolving needs of healthcare stakeholders.

Ashok Vardhan Ravinuthala is a Senior Director, Oncology Medical AI & Innovation at Pfizer, leading the design and scaling of AI and digital solutions across Oncology Medical Affairs. He focuses on translating advanced analytics and generative AI into practical tools that improve scientific engagement, operational efficiency, and measurable medical impact. He brings two decades of experience building AI and analytics solutions for big pharma across commercial and medical organizations in Oncology and other key specialty areas.

Vineet Rathi is a Principal at Axtria with 20+ years of experience driving commercial transformation for leading life sciences organizations. His work focuses on advancing AI-led innovation, particularly Agentic AI, to enable more autonomous, insight-driven decision-making across commercial functions.

He has presented at leading industry conferences, sharing perspectives on the future of AI-enabled commercial models. Vineet brings deep expertise across the broader commercial effectiveness domain, including sales force effectiveness, targeting, and incentive compensation, with a focus on translating innovation into measurable business impact.

Sid is an AI researcher and practitioner focused on building production-grade intelligent systems using large language models, deep learning, and advanced information retrieval. His work spans dialog systems, reinforcement learning, and enterprise AI applications. He has contributed to AI innovation at Google, Amazon, Meta, and Microsoft and has authored more than 120 publications and patent submissions in artificial intelligence. Sid holds a BS in Computer Science from IIT Kharagpur and a PhD in Bioinformatics from Arizona State University.

Anindya is a Principal at Viscadia, working at the intersection of forecasting and market research. Over 18 years in life sciences consulting, he has built deep expertise in oncology and rare diseases across a broad range of therapeutic areas. Anindya is focused on how AI and emerging technology can reshape commercial research workflows — starting with how teams and stakeholders actually work. A first-principles thinker, he is drawn to the behavioral and organizational dimensions of tech adoption as much as the tools themselves. He has been an active member of the PMSA community for five years.

Igor has over 25 years of Pharma Data, AI, and Analytics experience. Currently, Igor is leading Data Strategy, Data Platforms, Partnerships, and Innovations at JnJ pharma. Previously, Igor held data, AI, and Analytics leadership roles with Horizon/Amgen, Novartis, AstraZeneca, and Pfizer. Igor has PhD in Superstring Theory and MBA in Analytical Finance & Marketing from University of Chicago.

Jo Ann is the Global Data Strategy, Analytics and AI Practice Lead at Inizio Ignite, bringing over 20 years of C-level experience in healthcare, with a focus on digital technology and data-driven transformation. Her expertise spans AI and GenAI programs, data and analytics strategy, medical affairs innovation, and partnerships with leading technology and data organizations. Prior to Putnam, she was a Managing Director at Ernst & Young, where she led transformation initiatives across customer engagement, omnichannel marketing, and AI-driven commercial excellence. Jo Ann holds a master’s degree in computer science from NJIT, two bachelor’s degrees from Rutgers University, and serves on the board of the Northern NJ American Heart Association.

Niti Sawhney has 20 years of experience in end-to-end pharma commercial operations, including data management, insights generation, defining strategy, and running operations. She has vast expertise in building salesforce effectiveness solutions, brand and functional performance analytics with a focus on leveraging Gen AI and Agentic AI to drive organizational growth.

Mike leads the RWE technical solution team at Forian, working with external clients to conduct studies on Forian's robust RWD. Mike has worked as a Data Scientist in the RWD space for many years across both RWE and commercial analytics. He uses his experience to build custom study solutions for clients and develop Forian's internal study software suite. Prior to join Forian, Mike spent 5+ years at EVERSANA and holds a BS in Computer Science.

Yiran Shan is an Engagement Manager at MathCo, partnering with life sciences organizations to design and deliver AI-enabled analytics and decision-support solutions. She specializes in translating commercial and medical analytics needs into scalable products—spanning field-facing AI assistants, workflow automation, and the data/context foundations required to scale responsibly. Yiran works closely with cross-functional teams across analytics, engineering, and UX to move solutions from pilot to production and drive adoption. She focuses on practical, governance-ready approaches that improve speed-to-insight and enable measurable business impact.

Pulkit Sharma is focused on delivering real‑world impact by harnessing generative AI and advanced analytics. He previously served as an Engagement Manager at McKinsey & Company, where he advised clients on strategy, digital transformations, and GenAI initiatives, while also supporting private equity investors through commercial due diligence. With a background in machine learning from his postdoctoral research at the University of Oxford, Pulkit brings a rare combination of technical depth and strategic insight, along with a strong passion for applying data and AI to drive tangible business outcomes.

Pulkit is a data science lead with 8 years of experience delivering advanced analytics solutions for pharma organizations. His work spans across forecasting, marketing mix, targeting, and omnichannel orchestration across therapy areas ranging from consumer and aesthetic products to oncology, immunology & specialty products. He currently leads the data science stream at PharmaACE, building cutting-edge models for complex pharma use cases, and brings additional industry depth from earlier roles at ZS Associates & Genpact.

Mehul Shah is the Executive Director of Insights & Analytics at Bausch + Lomb, where he leads the organization’s data strategy to support commercial decision-making across ophthalmic pharmaceuticals. He oversees advanced analytics, forecasting, and performance insights that enable more effective targeting, engagement, and brand growth across eye care professionals. Mehul partners closely with cross-functional teams to translate complex data into actionable strategies that improve sales execution and market performance. He is known for building high-performing analytics teams and driving data-driven transformation within the pharmaceutical commercial organization.

Matthew Shindel has over ten years working in pharma and biotech where he has specialized in translating insights from real-world data into actionable growth strategies. He currently serves as the Associate Director of Insights & Analytics at Immunocore, where he leads U.S. commercial strategy and demand forecasting for KIMMTRAK. Prior to joining Immunocore, Matthew worked at Syneos Health Consulting where he lead over 60 engagements for Syneos' market access and commercial strategy practices.

Rachel Silvestrini, Ph.D. is VP of Global Business Insights and Analytics at Eli Lilly and Company, where she leads teams building AI and analytics solutions that shape commercial strategy. A former Associate Professor at Rochester Institute of Technology, Rachel brings a rare blend of academic rigor and industry leadership to the intersection of data science and business impact. She holds advanced degrees in Industrial Engineering from Arizona State University and Northwestern University.

Abhishek Narayan Singh is the Senior Vice President for Digital Human Health at Merck (known as MSD outside the US and Canada). Based at Merck’s global headquarters in New Jersey, Abhishek leads the digital, data and analytics transformation strategy across Human Health, driving meaningful impact for patients, customers and the business.

Sumanth Singh is the Head of Solutions Architecture (Global Development IT) at Regeneron, where he drives architecture strategy with a strong focus on modern data platforms, scalable system & data ecosystems, and analytics-driven transformation. With 18+ years of experience, he specializes in designing data architectures that integrate BI, data governance, and advanced analytics to enable agile, insight-driven decision-making across industries including life sciences and digital media.

He is a recognized thought leader in data architecture, with published research ( featured in the International Journal of Pharmaceutical Sciences) on the evolution from data lakes to data products in life sciences. Sumanth has recently presented at global forums such as SAP Sapphire and the SAP Transformation Excellence Summit, and has been recognized as a Qlik Luminary for his contributions to advancing modern BI and analytics practices.

Patrick Sipple is the Director of Artificial Intelligence, Policy & Channel at Bristol Myers Squibb, with 13 years of experience in pharmaceutical R&D and commercialization specializing in AI-driven forecasting and predictive modeling. Patrick has led cross-functional teams to deliver AI solutions including spearheading a Gross-to-Net prediction engine that reduced forecast variance by more than 50% for BMS’s largest brands and implementing scalable ML pipelines that accelerated patient opportunity modeling by 90%. Earlier in his career he drove manufacturing process optimization for over a dozen drug programs using predictive modeling. Patrick holds a Master of Science in Chemical Engineering from North Carolina State University and a Bachelor of Science in Biological Engineering from Cornell University.

With over 30 years in consumer data and analytics, Anne has achieved tremendous success as a strategic thinker, collaborator, and business expansion leader. She has demonstrated exceptional leadership in guiding the HealthWise Data team to develop forward-thinking strategies that have elevated the company’s comprehensive data product offerings.

Anne’s passion for data and analytics is contagious, inspiring everyone around her to think outside the box and embrace new challenges. Under her guidance, the team has delivered groundbreaking data products and services that have been successfully embraced by leading healthcare brands.

Anne is active in several professional organizations and nonprofits including Project Healthcare with the Nashville Entrepreneur Center, Entrepreneurs Organization and Women in Technology.

Mohammad is a director and product owner in data science and machine learning at AstraZeneca, with expertise in building data quality pipelines, single-source-of-truth systems, and predictive models for decision support. He partners closely with stakeholders to translate needs into scalable solutions and is advancing the strategic use of generative AI. He holds a PhD in biomedical engineering.

Sumanth Srinivas is Vice President, Commercialization AI Capabilities & Enablement at Bristol Myers Squibb. In this role, Sumanth is responsible for driving the strategy, roadmap, and business outcomes for AI-powered capabilities and solutions. Sumanth has held various positions in the pharmaceutical industry over the last twenty years including key leadership roles in Data Strategy, Analytics, Customer Experience, and Market Access at Merck and Boehringer Ingelheim.

Wei Sun is a Director at Lundbeck, where she focuses on initiatives in machine learning and generative AI to advance healthcare and pharmaceutical innovation. She builds and deploys machine learning and generative AI solutions that tackle real world challenges in pharmaceuticals. Wei is passionate about using data to unlock better ways of understanding and delivering care, and is always exploring new ideas at the edge of technology and innovation.

Aayush Tandon is a dynamic and visionary pharmaceutical leader with nearly two decades of experience spanning business planning, forecasting, and commercial analytics across Global and US markets. As Executive Director and Head of US Forecasting at Novartis, he leads the Forecasting Center of Excellence, overseeing demand forecasting for the entire US portfolio and building world class, scalable forecasting capabilities across multiple Therapeutic Areas. Prior to this role, Aayush held senior leadership positions across Commercial Analytics, Primary Market Research, Competitive Intelligence, and Business Development & Licensing, driving portfolio strategy and brand performance through advanced forecasting, AI powered predictive modeling, and actionable insights. His career includes impactful roles at leading organizations such as AstraZeneca and IQVIA, where he delivered high impact analytics and forecasting solutions across Oncology, Diabetes, Immunology, and Specialty portfolios. Aayush is an alumnus of IIT Bombay, where he completed the Executive Program in Business & HR Management, and holds a Bachelor’s degree in Pharmaceutical Sciences from Mumbai University. He also serves as a Board Member of the Pharmaceutical Management Science Association (PMSA), contributing to industry thought leadership in analytics and decision science.

Jean-Patrick Tsang is the Founder and President of Bayser, a Chicago-based consulting firm dedicated to sales and marketing for pharmaceutical companies. JP is an expert in data strategy and advanced analytics. JP has published 25+ papers, given 80+ talks at conferences, and completed 250+ projects. In a previous life, JP deployed Artificial Intelligence to automate the design of payloads for satellites. JP earned a Ph.D. in Artificial Intelligence from Grenoble University, advised 2 PhD students, and earned an MBA from INSEAD in Fontainebleau, France. He was the recipient of the 2015 PMSA Lifetime Achievement Award.

Nicole Ventrone is a Partner at Beghou, a life sciences consulting firm specializing in commercial strategy, data management, analytics, and AI solutions. She leads AI roadmap engagements for biopharma clients, helping commercial organizations navigate adoption through stakeholder research, behavioral segmentation, and change management. Nicole regularly presents and publishes on AI adoption in life sciences and serves as Vice President of the Healthcare Businesswomen's Association San Diego chapter.

Melissa Wagner is a media and marketing leader at Amgen, driven by a mission to make people’s lives easier, fuller, and longer. She brings deep expertise from her time at Merck, where she led integrated media strategies across U.S. Pharma, Rare Disease, and Oncology, as well as a decade on the agency side partnering with diverse healthcare clients. Known for fostering strategic partnerships and pioneering innovative “firsts,” Melissa is focused on delivering meaningful impact through forward-thinking marketing.

As Chief Insights and Decision Science Officer, Eden is leading a trailblazing strategy to integrate and develop data, insights, technology and generative AI capabilities across the US enterprise to elevate decision making as a science. Through this work, IDS will positively impact the ability of every associate in the organization to make incrementally better decisions in service of patients, customers and shareholders.

Eden possesses more than 25 years of broad global experience in the pharmaceutical and biotech industry, including 4 prior years with Novartis headquarters in Basel. Her career has spanned clinical operations, marketing, insights, analytics and forecasting, patient services, free drug foundations and field leadership.

Prior to leading Insights and Decision Science, Eden served as Chief Patient Experience Officer, establishing Novartis Patient Support to enable treatment access and longevity for patients prescribed Novartis medicines. As the leader of NPS, Eden led an innovative approach to bringing tech-forward partnerships together in service of patients, enabling Novartis to take a leadership position on access and reimbursement support to patients, while delivering superior experiences with Novartis-built and operated consumer technology, data and design at scale. Eden has a track record for growing and developing next-generation leaders across the industry. She is uniquely skilled in identifying new opportunities and creating teams that become force-multipliers capable of unlocking their collective power.

Prior to joining Novartis, Eden spent 14 years at Genentech and Roche, with increasing leadership roles in Oncology, Rheumatology and Respiratory across teams including Competitive intelligence, Forecasting and Analytics, Patient Support, Technology and Field Leadership. Eden attended Brigham Young University and holds degrees in microbiology and biochemistry.

Nuray Yurt, a senior leader at Merck, where she leads Market Access Operations, Insights, and Forecasting across Global and U.S. organizations. Nuray has held multiple leadership roles across big pharma and is recognized for her strong analytical approach, combined with compassion and integrity in how she leads and solves complex business problems. Based in New Jersey, she brings a global perspective to her work and is deeply committed to developing talent and driving meaningful impact.